Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.
about
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis.Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored VaccinesA Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.Recombinant modified vaccinia virus Ankara-based malaria vaccines.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part II.Defending against smallpox: a focus on vaccines.Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology.Generation and Production of Modified Vaccinia Virus Ankara (MVA) as a Vaccine Vector.Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?Are We Prepared in Case of a Possible Smallpox-Like Disease Emergence?Challenges and Achievements in Prevention and Treatment of Smallpox.A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses.Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice.Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines.Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial.Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster ModelClinical Advances in Viral-Vectored Influenza Vaccines
P2860
Q29994671-CCB3970D-7513-49A2-9D4F-BB58C3EBDEA5Q35800226-364A0EDA-2FC0-4D88-9BCC-7932DAD51915Q35928588-9C060CC1-15E8-4E1B-8CF5-CD9C1E3A76EDQ36057928-5AFD3F06-2906-4539-8791-ACE367BAB617Q38618898-64707782-13ED-4CDE-8897-BB70AD4CB489Q38638518-1B8714AD-4D19-4E97-8449-CCC4098E1B24Q38799357-030F3FCC-A9EA-4BEF-B50E-3DC9F47FF588Q40117821-6BF42416-605A-4030-8F88-A36BB9B3F517Q40259630-33E73943-E4F8-404A-ADA0-B97ADDDC9996Q45325213-61EC83D1-0E85-4294-86EA-F14D7AA3216AQ47116100-81E6DC46-3A3D-4E03-AA86-4CB50C613002Q47547852-41A289AF-4560-4A8F-87BC-CF612CC81674Q51336011-4652DE96-64F6-40E1-A816-22148CF98237Q52623520-B9B2150B-F4DF-41C3-8B56-9D8D9E96E2F4Q55114818-9F555A52-3E9D-4D84-B009-B4CB9132D852Q55329093-F06EFAB2-2DB9-4049-A19A-D46AE82649B8Q56395905-1B155437-3B14-4A75-928C-783DE27904B2Q57094631-4289CA5C-66A4-403A-97BB-29F844451C49
P2860
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Safety and Immunogenicity of M ...... olled Clinical Phase II Trial.
@ast
Safety and Immunogenicity of M ...... olled Clinical Phase II Trial.
@en
type
label
Safety and Immunogenicity of M ...... olled Clinical Phase II Trial.
@ast
Safety and Immunogenicity of M ...... olled Clinical Phase II Trial.
@en
prefLabel
Safety and Immunogenicity of M ...... olled Clinical Phase II Trial.
@ast
Safety and Immunogenicity of M ...... olled Clinical Phase II Trial.
@en
P2093
P2860
P356
P1476
Safety and Immunogenicity of M ...... rolled Clinical Phase II Trial
@en
P2093
Alfred von Krempelhuber
David Barker
Edgar Turner Overton
Eva Wagner
Garth Virgin
Jane Maclennan
Jutta Müller
Nathaly Arndtz-Wiedemann
Nicole Bädeker
P2860
P304
P356
10.1093/OFID/OFV040
P577
2015-04-01T00:00:00Z